MORTIMER IAN
Insider CIK 1619961 · XENE PRESIDENT, CEO & INTERIM CFO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2026-09-30 | 2026-10-01 | 30,000 | $37.38 | $1.12M | 49,923 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-13 | 2026-03-13 | 7,308 | $55.23 | $403.6K | 19,923 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-03-12 | 2026-03-13 | 12,500 | — | $0 | 37,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-03-12 | 2026-03-13 | 12,500 | — | $0 | 27,231 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-10 | 2026-03-11 | 11,269 | $60.11 | $677.4K | 14,731 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-03-09 | 2026-03-11 | 25,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-03-09 | 2026-03-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-03-09 | 2026-03-11 | 20,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-03-09 | 2026-03-11 | 105,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-03-09 | 2026-03-11 | 75,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-03-09 | 2026-03-11 | 65,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-03-09 | 2026-03-11 | 20,000 | — | $0 | 26,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-09 | 2026-03-11 | 65,000 | $62.06 | $4.03M | 6,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-03-09 | 2026-03-11 | 65,000 | $9.44 | $613.6K | 71,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-09 | 2026-03-11 | 61,652 | $60.08 | $3.70M | 6,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-09 | 2026-03-11 | 43,348 | $59.26 | $2.57M | 72,652 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-03-09 | 2026-03-11 | 105,000 | $4.75 | $498.8K | 111,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-09 | 2026-03-11 | 2,449 | $61.26 | $150.0K | 6,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-09 | 2026-03-11 | 10,072 | $60.47 | $609.1K | 8,449 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-09 | 2026-03-11 | 12,479 | $59.50 | $742.5K | 18,521 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-03-09 | 2026-03-11 | 25,000 | $3.10 | $77.5K | 31,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-09 | 2026-03-11 | 21,515 | $60.49 | $1.30M | 6,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-09 | 2026-03-11 | 31,694 | $59.88 | $1.90M | 27,515 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-09 | 2026-03-11 | 21,791 | $58.81 | $1.28M | 59,209 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-03-09 | 2026-03-11 | 75,000 | $8.40 | $630.0K | 81,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-01-09 | 2026-01-09 | 350,000 | — | $0 | 350,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-01-09 | 2026-01-09 | 65,000 | — | $0 | 65,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-01-02 | 2026-01-02 | 40,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-01-02 | 2026-01-02 | 2,062 | $44.93 | $92.6K | 6,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-01-02 | 2026-01-02 | 40,000 | $7.49 | $299.6K | 46,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-01-02 | 2026-01-02 | 37,938 | $44.40 | $1.68M | 8,062 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2025-12-08 | 2025-12-09 | 8,820 | $45.59 | $402.1K | 8,010 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2025-12-08 | 2025-12-09 | 2,010 | $46.32 | $93.1K | 6,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2025-12-05 | 2025-12-09 | 14,375 | $45.03 | $647.3K | 16,830 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2025-11-28 | 2025-12-03 | 97 | $45.01 | $4.4K | 31,205 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2025-10-01 | 2025-10-01 | 25,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2025-10-01 | 2025-10-01 | 25,000 | $7.69 | $192.3K | 56,302 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2025-10-01 | 2025-10-01 | 25,000 | $40.16 | $1.00M | 31,302 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2025-03-12 | 2025-03-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2025-03-12 | 2025-03-13 | 275,000 | — | $0 | 275,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2025-01-27 | 2025-01-27 | 16,315 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2025-01-27 | 2025-01-27 | 15,166 | $17.76 | $269.3K | 46,468 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2025-01-27 | 2025-01-27 | 1,149 | $41.07 | $47.2K | 31,302 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2025-01-27 | 2025-01-27 | 15,166 | $40.46 | $613.6K | 31,302 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2025-01-27 | 2025-01-27 | 1,149 | $17.76 | $20.4K | 32,451 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2025-01-24 | 2025-01-27 | 22,468 | — | $0 | 16,315 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2025-01-24 | 2025-01-27 | 22,468 | $40.20 | $903.2K | 31,302 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2025-01-24 | 2025-01-27 | 22,468 | $17.76 | $399.0K | 53,770 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2025-01-23 | 2025-01-27 | 16,217 | — | $0 | 38,783 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2025-01-23 | 2025-01-27 | 16,217 | $40.08 | $650.0K | 31,302 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2025-01-23 | 2025-01-27 | 16,217 | $17.76 | $288.0K | 47,519 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2024-03-11 | 2024-03-12 | 250,000 | — | $0 | 250,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2023-05-24 | 2023-05-26 | 42,592 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2023-05-24 | 2023-05-26 | 6,172 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2023-05-24 | 2023-05-26 | 20,576 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2023-05-24 | 2023-05-26 | 3,902 | $41.84 | $163.3K | 40,887 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2023-05-24 | 2023-05-26 | 42,592 | $9.44 | $402.1K | 48,592 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2023-05-24 | 2023-05-26 | 7,310 | $41.84 | $305.9K | 41,282 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2023-05-24 | 2023-05-26 | 6,172 | $9.85 | $60.8K | 33,880 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2023-05-24 | 2023-05-26 | 1,171 | $41.84 | $49.0K | 32,709 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2023-05-24 | 2023-05-26 | 20,576 | $9.85 | $202.7K | 44,789 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2023-05-24 | 2023-05-26 | 1,407 | $41.49 | $58.4K | 31,302 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2023-05-24 | 2023-05-26 | 13,179 | $41.37 | $545.2K | 27,708 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2023-05-24 | 2023-05-26 | 17,069 | $41.44 | $707.3K | 24,213 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2023-03-10 | 2023-03-14 | 380,000 | — | $0 | 380,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2022-03-10 | 2022-03-14 | 400,000 | — | $0 | 400,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2021-06-03 | 2021-06-03 | 125,000 | — | $0 | 125,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2021-03-12 | 2021-03-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2020-03-12 | 2020-03-13 | 145,000 | — | $0 | 145,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2019-09-16 | 2019-09-18 | 135,000 | — | $0 | 135,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2018-03-12 | 2018-03-13 | 105,000 | — | $0 | 105,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2017-10-23 | 2017-10-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2017-08-10 | 2017-08-14 | 10,000 | $2.90 | $29.0K | 14,300 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2017-08-10 | 2017-08-14 | 5,000 | $2.85 | $14.3K | 6,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2017-03-13 | 2017-03-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2016-06-24 | 2016-06-28 | 1,000 | $6.10 | $6.1K | 1,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2016-06-24 | 2016-06-28 | 2,000 | $6.25 | $12.5K | 3,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2016-06-24 | 2016-06-28 | 1,300 | $6.30 | $8.2K | 4,300 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2016-06-24 | 2016-06-28 | 1,000 | $6.15 | $6.2K | 1,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2016-03-11 | 2016-03-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2015-12-18 | 2015-12-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2015-03-17 | 2015-03-19 | 55,000 | — | $0 | 55,000 | SEC↗ |